ADVERTISEMENT

Protect against drug-drug interactions with anxiolytics

Current Psychiatry. 2006 May;05(05):16-28
May 1, 2006|Current Psychiatry
Mohamed I. Ramadan, MD;Steve F. Werder, DO;Sheldon H. Preskorn, MD
Author and Disclosure Information

Mohamed I. Ramadan, MD
Staff psychiatrist, Mohave Mental Health Clinic, Kingman, AZ
Steve F. Werder, DO
Assistant professor, Department of psychiatry and behavioral sciences, University of Kansas, School of Medicine, Wichita

Sheldon H. Preskorn, MD
Chairman, Department of psychiatry and behavioral sciences, University of Kansas, School of Medicine, Wichita

Safe use of benzodiazepines, buspirone, and propranolol.

Dr. Preskorn has received grants or has been a consultant or speaker for Abbott Laboratories, AstraZeneca Pharmaceuticals, Boehringer-Ingelheim, Bristol-Myers Squibb Co., Merck & Co., Eisai, Eli Lilly and Co., GlaxoSmithKline, Janssen Pharmaceutica, Johnson & Johnson, Novartis Pharmaceuticals Corp., Organon, Otsuka America Pharmaceutical, Pfizer, Solvay Pharmaceuticals, Sanofi-Aventis, and Wyeth.

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT